Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Puerto Rico Healthcare Daily.
Press releases published on July 2, 2025
Oragenics Completes Approximately $16.5 Million Offering
GlobeNewswire
·
July 2, 2025
SARASOTA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal therapeutics for neurological disorders, today announced the successful closing of its previously …
Cellectar Biosciences Announces Closing of $6.9 Million Underwritten Public Offering, including Full Exercise of Over-Allotment Option
GlobeNewswire
·
July 2, 2025
FLORHAM PARK, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced …
Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate
GlobeNewswire
·
July 2, 2025
GAITHERSBURG, Md., July 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the expansion of its proprietary NARCANDirect® online distribution network to include KLOXXADO® (naloxone HCl) Nasal Spray 8 mg. The platform …
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
GlobeNewswire
·
July 2, 2025
PASADENA, CALIF, July 02, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical company, today announced the closing of a private placement with accredited investors for the purchase and …
Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
GlobeNewswire
·
July 2, 2025
WALTHAM, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the closing of …
New Study: 4 in 5 Americans Have Experienced Heat Exhaustion Symptoms, Ergodyne Finds
GlobeNewswire
·
July 2, 2025
St. Paul, MN, July 02, 2025 (GLOBE NEWSWIRE) -- 4 in 5 Americans have experienced the warning signs of heat exhaustion, according to a new survey for Extreme Heat Month this July from pioneering safety work gear provider Ergodyne. The survey marks the …
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
GlobeNewswire
·
July 2, 2025
LAKEWOOD, Colo., July 02, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2026 at approximately 8:00 A.M. Eastern time on Tuesday, August 5, 2025. About …
Financing Innovation: Proposal for Novel Adaptive Platform Trial Fund Offers New Model for ALS Drug Development
GlobeNewswire
·
July 2, 2025
Cambridge, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- A team of researchers from the MIT Sloan School of Management, the Sean M. Healey …
Global Real-World Evidence Solution Market to Grow at a Substantial Growth Rate of ~8% by 2032 | DelveInsight
GlobeNewswire
·
July 2, 2025
New York, USA, July 02, 2025 (GLOBE NEWSWIRE) -- Global Real-World Evidence Solution Market to Grow at a Substantial Growth Rate of ~8% by 2032 | DelveInsight The real-world evidence solutions market is largely driven by the increasing prevalence of …
Houston to host 2025 AAU Junior Olympic Games July 22 - August 2
GlobeNewswire
·
July 2, 2025
Houston, TX, July 02, 2025 (GLOBE NEWSWIRE) -- The Amateur Athletic Union (AAU), in conjunction with the Harris County - Houston Sports Authority (HCHSA), will host the 2025 AAU Junior Olympic Games in five (5) different venues across the Greater Houston …
U.S. Oral Surgery Management Names Doug Drew CEO
GlobeNewswire
·
July 2, 2025
IRVING, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management (USOSM) developed and implemented a succession plan earlier this year to ensure a smooth transition from long- time CEO, Richard Hall. Hall is transitioning from his role as …
Intuitive’s da Vinci 5 Surgical System Receives CE Mark
GlobeNewswire
·
July 2, 2025
SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark …
US Probiotics Market Poised for Strong Growth Amid Surging Demand for Digestive Health Solutions
GlobeNewswire
·
July 2, 2025
Delray Beach, FL, July 02, 2025 (GLOBE NEWSWIRE) -- A new research report, “US Probiotics Market by Ingredient (Bacteria and Yeast), Product Type (Functional Food …
Athelas Launches AIR: The Only EHR with Fully Integrated Ambient Scribing, AI Agents, and Hands-Free RCM Automation
GlobeNewswire
·
July 2, 2025
MOUNTAIN VIEW, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the launch of Athelas AIR, its next-generation electronic health record (EHR) system designed to meet the needs of health …
Cyclacel Pharmaceuticals Announces Stock Split
GlobeNewswire
·
July 2, 2025
BERKELEY HEIGHTS, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it expects to implement a …
Windtree Announces Issuance of Istaroxime Patent for the United States for Acute Heart Failure
GlobeNewswire
·
July 2, 2025
1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to …
Primo Biotechnology Secures A Funding and Targets 2026 IPO to Strengthen Global Radiopharmaceutical Strategy
GlobeNewswire
·
July 2, 2025
TAIPEI, Taiwan, July 02, 2025 (GLOBE NEWSWIRE) -- Primo Biotechnology Co., Ltd., a pioneering radiopharmaceutical company in Taiwan, announced the successful completion of its NT$220 million Series A funding round. With total capital raised now exceeding …
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
GlobeNewswire
·
July 2, 2025
OCALA, Fla., July 02, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a presentation and discussion on immunotherapies involving AIM’s drug Ampligen at the recent U.S.-Poland Science and Technology …
The International Myeloma Foundation Proudly Announces EMA-CHMP Positive Qualification Advice to i2TEAMM Novel Biomarker Procedure Application on the Use of MRDnegCR as an Intermediate Early Endpoint for Conditional Market Approval in Myeloma Clinical…
GlobeNewswire
·
July 2, 2025
STUDIO CITY, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and the collaborative stakeholder group i2TEAMM (International Independent Team for Endpoint Approval of Myeloma MRD), which includes top global myeloma …
AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions
GlobeNewswire
·
July 2, 2025
DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent solutions, today announced the sale of its Smart Square® scheduling software to symplr®, a leader in enterprise healthcare operations software. In …